16:46:13 EDT Tue 18 May 2021
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

News for U:CHRS from 2020-05-19 to 2021-05-18 - 34 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2021-05-07 16:01U:CHRSNews ReleaseCoherus BioSciences to Present at the Bank of America Health Care Conference
2021-05-06 16:01U:CHRSNews ReleaseCoherus BioSciences Reports First Quarter 2021 Financial Results and  Immuno-oncology and Biosimilar Pipeline Progress
2021-04-30 16:15U:CHRSNews ReleaseCoherus BioSciences Announces New Employment Inducement Grants
2021-04-30 08:15U:CHRSNews ReleaseCoherus BioSciences to Report First Quarter 2021 Financial Results on May 6th
2021-04-29 07:30U:CHRSNews ReleaseJunshi Biosciences and Coherus Announce Toripalimab First-Line Nasopharyngeal Carcinoma Clinical Data to be Showcased in Plenary Session at 2021 ASCO Annual Meeting
2021-04-29 07:30U:CHRSNews ReleaseJunshi Biosciences and Coherus Announce Toripalimab First-Line Nasopharyngeal Carcinoma Clinical Data to be Showcased in Plenary Session at 2021 ASCO Annual Meeting
2021-04-23 08:00U:CHRSNews ReleaseCoherus Announces Toripalimab Achieved Primary Endpoints of Progression Free Survival and Overall Survival in Interim Analysis of Phase 3 Clinical Trial in First-Line Esophageal Squamous Cell Carcinoma
2021-04-20 08:00U:CHRSNews ReleaseCoherus Announces Closing of Sale of Common Stock to Immuno-Oncology Partner Junshi Biosciences
2021-03-03 06:45U:CHRSNews ReleaseJunshi Biosciences and Coherus BioSciences Announce Initiation of Rolling Submission of BLA for Toripalimab to the U.S. FDA for the Treatment of Nasopharyngeal Carcinoma
2021-03-03 06:45U:CHRSNews ReleaseJunshi Biosciences and Coherus BioSciences Announce Initiation of Rolling Submission of BLA for Toripalimab to the U.S. FDA for the Treatment of Nasopharyngeal Carcinoma
2021-02-25 08:45U:CHRSNews ReleaseCoherus Management to Present at Upcoming Investor Conferences
2021-02-24 16:01U:CHRSNews ReleaseCoherus BioSciences Reports Fourth Quarter and Full Year 2020 Financial Results
2021-02-18 08:30U:CHRSNews ReleaseCoherus BioSciences to Report Fourth Quarter and Full Year 2020 Financial Results on February 24th
2021-02-17 07:30U:CHRSNews ReleaseCoherus BLA Filing for Adalimumab Biosimilar Candidate  Accepted by FDA for Review
2021-02-16 08:00U:CHRSNews ReleaseCoherus Announces CFO Transition Plans
2021-02-02 08:30U:CHRSNews ReleaseCoherus BioSciences to Receive $50 million Strategic Investment from Immuno-Oncology Partner Junshi Biosciences
2021-02-01 07:53U:CHRSNews ReleaseJunshi Biosciences and Coherus BioSciences Announce Collaboration to Co-Develop Anti-PD-1 Antibody, Toripalimab, in U.S. and Canada
2021-02-01 05:30U:CHRSNews ReleaseCoherus BioSciences to expand late-stage pipeline to immuno-oncology with in-license of Junshi Biosciences ’ PD-1, toripalimab, in United States and Canada
2021-01-22 16:01U:CHRSNews ReleaseCoherus BioSciences Announces New Employment Inducement Grants
2021-01-07 16:01U:CHRSNews ReleaseCoherus BioSciences Appoints Alan Mendelson and Mark Stolper to Board of Directors
2021-01-05 16:01U:CHRSNews ReleaseCoherus BioSciences Management to Present at the 39th Annual J.P. Morgan Healthcare Conference
2020-12-21 16:02U:CHRSNews ReleaseCoherus BioSciences Announces New Employment Inducement Grants
2020-11-20 16:01U:CHRSNews ReleaseCoherus BioSciences Announces New Employment Inducement Grants
2020-11-05 16:02U:CHRSNews ReleaseCoherus BioSciences Reports Third Quarter 2020 Financial Results
2020-10-22 16:15U:CHRSNews ReleaseCoherus BioSciences to Report Third Quarter Financial Results on November 5th
2020-10-16 09:30U:CHRSNews ReleaseCoherus BioSciences Announces New Employment Inducement Grants
2020-09-18 11:02U:CHRSNews ReleaseCoherus BioSciences Announces New Employment Inducement Grants
2020-08-21 09:30U:CHRSNews ReleaseCoherus BioSciences Announces New Employment Inducement Grants
2020-08-06 16:02U:CHRSNews ReleaseCoherus BioSciences Reports Second Quarter 2020 Financial Results
2020-08-03 16:49U:CHRSNews ReleaseCoherus BioSciences Appoints Kimberly Tzoumakas, J.D. to Board of Directors
2020-07-17 09:30U:CHRSNews ReleaseCoherus BioSciences Announces New Employment Inducement Grants
2020-07-16 09:30U:CHRSNews ReleaseCoherus BioSciences to Report Second Quarter Financial Results on August 6th
2020-06-19 09:30U:CHRSNews ReleaseCoherus BioSciences Announces New Employment Inducement Grants
2020-05-26 18:16U:CHRSNews ReleaseEssent Group Set to Join S&P MidCap 400; Coherus BioSciences, Patterson-UTI Energy to Join S&P SmallCap 600